Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07283653 · ClinicalTrials.gov registry record · NA

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

A NA study of Dysphagia and DIGEST, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT07283653 is a NA study of Dysphagia and DIGEST that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 85 participants, below the 170-participant average among 35 other Dysphagia trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07283653, a NA study of Dysphagia and DIGEST, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.

Interventions

  • OTHER No intervention
  • OTHER DIGEST Training Program
  • OTHER DIGEST Training + Practice Facilitation

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2025-06-01
Est. Completion 2029-01-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT07283653

The ClinicalTrials.gov registry entry for NCT07283653 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 35 other Dysphagia trials with a reported enrollment target (50% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Dysphagia appearing as the primary indexed condition, and to 3 interventions - of which No intervention is the first listed.

NCT07283653 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07283653 about?

NCT07283653 is a clinical study titled "Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial". To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.

What is the current status of trial NCT07283653?

This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2025-06-01. Estimated completion is 2029-01-31.

What conditions does trial NCT07283653 study?

This clinical trial studies the following conditions: Dysphagia, DIGEST, Evidence Based Measurement, Randomized Implementation.

What interventions are being tested in trial NCT07283653?

The interventions under investigation include: No intervention (OTHER), DIGEST Training Program (OTHER), DIGEST Training + Practice Facilitation (OTHER).

Who is sponsoring clinical trial NCT07283653?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07283653 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dysphagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.